| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0004 |